What is Morgans saying about Ramsay Healthcare and Karoon Energy shares?

Both companies released their latest earnings reports last week.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

S&P/ASX 200 Index (ASX: XJO) shares finished at a record high of 9,198.6 points on the last day of earnings season on Friday.

Meanwhile, experts continue to review stacks of company reports so they can re-rate the stocks as buys, holds, or sells.

Here's what Morgans thinks of these two ASX 200 shares following their earnings reports last week.

Two brokers pointing and analysing a share price.

Image source: Getty Images

Ramsay Health Care Ltd (ASX: RHC)

The Ramsay Healthcare share price is up 19% over the past 12 months.

The ASX 200 healthcare share reached a 52-week high of $43.65 on Friday.

Last week, Ramsay Healthcare reported a 1H FY26 net profit after tax (NPAT) attributable to owners of $160.7 million.

That was a major improvement on the $104.9 million loss recorded in 1H FY25.

The ASX 200 healthcare share will pay a fully franked interim dividend of 42.5 cents per share, up 6.3% on 1H FY25.

Morgans kept its hold rating on Ramsay Healthcare shares after reviewing the 1H FY26 results.

The broker said:

1HFY26 underlying net profit exceeded expectations, assisted by lower finance charges and favourable non-controlling interest movements.

Operationally, performance was solid, led by improving Australian activity and earnings, while UK acute held its own, Elysium remained soft, but continues its gradual turnaround, and EU is stable on better cost control.

While progress is being made across the portfolio, the sustainability of profitable remains in question, with ongoing cost headwinds, the early stage of a multi-year transformation program in Australia and a largely qualitative FY26 outlook.

The broker raised its 12-month share price target on Ramsay Healthcare from $35.22 to $40.77.

Karoon Energy Ltd (ASX: KAR)

The Karoon Energy share price is up 5.8% over the past 12 months.

Last week, Karoon Energy reported sales revenue of US$628.6 million for full-year FY25, down from US$776.5 million in FY24.

The company said the decline reflected lower realised oil prices and slightly lower sales volumes.

Underlying EBITDAX was US$388.8 million, down 21% year-over-year.

The underlying NPAT halved to US$107.5 million, down from US$214 million in FY24. Statutory NPAT was US$125.5 million.

Karoon Energy shares will pay a final dividend of 3.1 cents per share, fully franked. 

Morgans maintained its hold rating and commented that Karoon Energy was "entering a challenging 1H26".

The broker said:

A solid set of earnings and dividend ahead of estimates were not enough to offset new operational issues at Who Dat, Neon delay, moderated share buyback and CFO departure.

Underlying EBITDAX of US$389m beat MorgansF (+3%) and consensus (+2%), with a larger U/L NPAT beat driven by lower tax and D&A.

KAR flagged a Who Dat riser leak, shutting in 30% of field production. Neon FID has been delayed to 2027 at least.

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Three young nerds dressed in suits with thinking caps and lightbulbs
Broker Notes

Brokers name 3 ASX shares to buy right now

Let's find out which shares top brokers are feeling bullish about this week.

Read more »

A woman in a red dress holding up a red graph.
Broker Notes

4 ASX shares Macquarie says could return more than 40%

The broker has made some bold predictions.

Read more »

A woman leans forward with her hand behind her ear, as if trying to hear information.
Broker Notes

Down 60%, are Cochlear shares now a bargain buy?

A leading analyst provides his outlook for Cochlear’s beaten-down shares.

Read more »

A businessman hugs his computer and smiles.
Broker Notes

Why this ASX stock is a 'compelling value play'

Value investors might want to check out this share that Bell Potter is bullish on.

Read more »

Man holding a calculator with Australian dollar notes, symbolising dividends.
Broker Notes

Should I buy Rio Tinto shares for passive income?

A leading analyst provides his outlook for Rio Tinto shares and dividends.

Read more »

Woman with her fingers crossed and eyes shut.
Broker Notes

4 ASX shares upgraded by brokers this week

Brokers have new confidence in TPG Telecom, Deep Yellow, and other stocks this week.

Read more »

Three adorable children sit side by side at a table wearing upturned colanders on their heads fixed with shining light bulbs as they smile at the camera.
Broker Notes

Buy, hold, sell: Nick Scali, Nyrada, Wesfarmers shares

Experts reveal their ratings on three ASX shares in the retail and biotech segments. 

Read more »

A young woman smiling and looking happy, indicating a positive share price movement on the ASX market.
Broker Notes

8 ASX 200 shares with renewed buy ratings this week

Brokers retained a positive view on CSL, GQG Partners, ANZ, and other shares this week. 

Read more »